Pfizer partners with many medical, scientific, patient and civic organizations to support their programs and activities, such as health education and scientific research. This support takes many forms, including grants, charitable contributions and partnerships for efforts that strengthen communities, and work toward a healthier world. Working with these organizations allows Pfizer to better understand the needs of the patients who take our medicines, while helping these medical, scientific and patient organizations inform and address the needs of those they serve.

Pfizer is committed to the principle of transparency — the disclosure of activities reflecting participation in efforts of public interest. These include such areas as funding for educational activities, the status of Pfizer's U.S. pharmaceutical post-marketing commitments, Pfizer's pipeline of experimental medicines, the registration and reporting of results of clinical trials, political contributions in the U.S. and payments to U.S. health care professionals

The information reported here includes grants to support independent medical education, support for fellowship, scholarship and visiting professorship programs, grants to patient organizations, medical and scientific associations, and academic or other medical centers, charitable contributions, healthcare-related support to civic organizations and healthcare-related non-promotional sponsorships to organizations.

For descriptions of types of support, please visit our descriptions section.

In addition, funding activities made by the Pfizer Foundation are aggregated and reported in an annual IRS 990 filing. This information is available on the Web site

Pfizer U.S. medical, scientific and patient education grants, charitable contributions and other healthcare-related funding requests are updated on a quarterly basis. Support provided beginning in 2008 is listed here:


Pfizer maintains a standard of ethical business conduct precluding any inappropriate influence on the content of funded programs.

Wyeth Pharmaceuticals Grants and Donations Report

In October, 2009, Pfizer acquired Wyeth Pharmaceuticals — an organization with a long tradition of supporting health-related and community organizations including professional health care associations, patient advocacy groups, medical schools, hospitals and medical societies. The following reports list grants provided in 2008 and 2009 by the Wyeth U.S. Pharmaceuticals Division, specifically to those organizations and entities headquartered in the U.S. or Puerto Rico.

Grant information in each report is organized in alphabetical order by the name of the organization receiving funding, the name/title of the grant/donation, and the dollar amount.